Adiponectin levels are known to be decreased in conditions such as obesity, insulin resistance, and type 2 diabetes (250), and the administration of glucocorticoids and androgens has been shown to reduce adiponectin levels (251, 252). Here, ADIPOQ is linked to type 2 diabetes mellitus.